The Maeve Carr Rare Cancers Survivorship Program
Literature, news and videos pertinent to
The Maeve Carr Rare Cancers Survivorship Program
The Operating Room of the Future – Video regarding the pathbreaking work of InSightec
based in Tirat Carmel, Israel, www.insightec.com
This video is an example. Replace or remove this video per the individual program
- Advaxis, Inc., GOG Foundation, Inc., Jan. 7, 2015 – Advaxis and the GOG Foundation, Inc. to Collaborate on Global Phase 3 Clinical Trial of ADXS-HPV in Cervical Cancer Study to Evaluate Advaxis’s Lead Cancer Immunotherapy in High-Risk, Locally Advanced Cervical Cancer
- Vinegar Screening for Cervical Cancer Saves Lives at Low Cost
- ASCO: Vinegar Test May Reduce Cervical Ca Deaths
- Vinegar cancer test saves lives, India study finds
- Tiny capsule effectively kills cancer cells
- Life-Saving DNA Test Overlooked in Rise of Colon Cancer
- Aiming For An HPV Vaccine Cheap Enough For The Developing World
- HPV DNA Testing Over 50 Percent More Sensitive Than Cytology Testing
- Final Results Of First Independent Study Highlight Clinical Effectiveness Of Cervista HPV HR Test
- A New Study Shows That Testing For HPV Genotypes 16 And 18 Detects Cervical Pre-Cancer Missed By Pap Test
- HPV Infection Linked To Increased Risk Of Skin Cancer
- Dynavax Awarded NIH Grant To Explore Feasibility Of Universal Papilloma Virus Vaccine
- International Conference Focuses On HPV's Impact On Women
- MorphoSys Receives Research Grant To Advance Anti-CD38 Cancer Program MOR202 And Explore Relevant Biomarkers
- Neogenix Oncology Files Patent Application For The 16C3 Antigen
- Setback for cancer test hopes - by Helen Briggs Health reporter, BBC News
Maeve Carr Rare Cancers Survivorship Program
is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Program Advocacy Services.
For more information about this special program, please click on...
Federal Tax I.D.: EIN 86-0818253